Table 1 Phenotypes.

From: Inclusion of endophenotypes in a standard GWAS facilitate a detailed mechanistic understanding of genetic elements that control blood lipid levels

Phenotype

Abbreviation

n

Min

Max

Mean

SD

Endophenotypes

Intermediates in cholesterol biosynthesis

Squalene

Sq

245

0.70

17.30

4.96

3.69

Lanosterol

Lan

284

1.43

5.89

3.42

0.91

Lathosterol

Lat

299

13.06

96.99

49.85

17.15

Desmosterol

Des

300

22.33

123.63

68.35

20.06

Sum of intermediates

Sint

300

36.15

222.51

129.05

35.00

Phytosterols

Betasitosterol

Bsit

297

45.36

470.17

186.60

96.30

Campesterol

Cste

288

106.68

862.77

392.42

158.37

Stigmasterol

Stig

249

0.16

2.56

1.14

0.48

Sum of phytosterols

Sphy

290

187.96

1253.79

577.60

232.74

Microbiota-derived sterols

Coprostanol

Csta

298

1.95

31.12

13.66

6.35

Epicoprostanol

Esta

276

0.23

5.41

2.23

1.11

Sum of microbiota-derived sterols

Sste

303

2.17

35.01

15.84

7.28

End-point phenotypes

LDL-Cholesterol

LDL-C

296

30.82

86.53

57.70

10.67

HDL-Cholesterol

HDL-C

317

13.00

57.00

36.19

7.92

Total Cholesterol

TC

297

67.78

137.84

100.88

13.88

Triglycerides

TG

295

42.57

200.12

119.68

31.02

  1. All endophenotypes were measured in µg/dl. End-point phenotypes were measured in mg/dl.
  2. SD = standard deviation of the mean.